GSAM unveils portfolio investing in healthcare companies at 'forefront' of innovation
Four key investment areas including genomics and digitisation
The pandemic has 'supercharged' demand for healthcare innovation, according to GSAM's Luke Barrs
Goldman Sachs Asset Management (GSAM) has launched a new portfolio that will provide exposure to global companies at the "forefront" of healthcare innovation, with a focus on genomics, precision medicine, minimally invasive procedures and digitisation.
The Goldman Sachs Global Future Health Care Equity Portfolio, a new sub-fund of the UCITS-qualifying Luxembourg-domiciled Goldman Sachs Funds SICAV, will be managed by GSAM's 80-person fundamental equity...
More on Equities
Back to Top
